TS
MED icon

True Signal’s Medifast MED Stock Holding History

True Signal’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$825K Buy
+7,155
New +$833K 0.62% 41

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

True Signal's MED Position: Q4 2022 in Review

True Signal opened a new position in Medifast (MED) in Q4 2022: 7,155 shares worth $825K. The stake represents 0.62% of the portfolio and ranks #41 among its holdings.

277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

  • True Signal held 7,155 shares of Medifast worth $825K as of Q4 2022.
  • Medifast was a new True Signal position in Q4 2022.
  • Medifast made up 0.62% of True Signal's portfolio in Q4 2022, its #41 holding.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on True Signal's 13F filing for Q4 2022, filed 26 Jan 2023.